Oramed Pharmaceuticals has a proprietary platform technology that allows for the oral delivery of drugs that are presently only available via injection.
Flagship product oral insulin capsule (ORMD-0801) for treatment of diabetes.  
Successfully completed Phase IIb US FDA trial for type 2 diabetes.  
Experienced management team with many years of pharmaceutical experience.
Multiple patent families have been granted in numerous countries.